Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

M. Vieito Villar; J. M. Sepúlveda Sánchez; V. Moreno Garcia; G. Lombardi; A. Stradella; R. H. Dahlrot; C. A. Haslund; M. Geurts; E. Pineda; P. Brandal; F. Y .F. L. De Vos; M. A. Vaz Salgado; M. Martinez Garcia; M. Macchini; B. Amoroso; T. Sanchez; B. Hanna; X. Li; Z. Nikolova; M. Simonelli

doi:10.1016/j.annonc.2023.09.1694

Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

M. Vieito Villar, J. M. Sepúlveda Sánchez, V. Moreno Garcia, G. Lombardi, A. Stradella, R. H. Dahlrot, C. A. Haslund, M. Geurts, E. Pineda, P. Brandal, F. Y .F. L. De Vos, M. A. Vaz Salgado, M. Martinez Garcia, M. Macchini, B. Amoroso, T. Sanchez, B. Hanna, X. Li, Z. Nikolova, M. Simonelli

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Dansk
Artikelnummer	500O
Tidsskrift	Annals of Oncology
Vol/bind	34
Udgave nummer	Suppl. 2
Sider (fra-til)	S392
Antal sider	1
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2023.09.1694
Status	Udgivet - okt. 2023
Begivenhed	ESMO Congress 2023 - Madrid, Spanien Varighed: 20 okt. 2023 → 24 okt. 2023 https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2023

Konference

Konference	ESMO Congress 2023
Land/Område	Spanien
By	Madrid
Periode	20/10/2023 → 24/10/2023
Internetadresse	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2023

Bibliografisk note

Abstrakt No. 500O

Adgang til dokumentet

10.1016/j.annonc.2023.09.1694

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Villar, M. V., Sánchez, J. M. S., Garcia, V. M., Lombardi, G., Stradella, A., Dahlrot, R. H., Haslund, C. A., Geurts, M., Pineda, E., Brandal, P., De Vos, F. Y. . F. L., Salgado, M. A. V., Garcia, M. M., Macchini, M., Amoroso, B., Sanchez, T., Hanna, B., Li, X., Nikolova, Z., & Simonelli, M. (2023). Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study. Annals of Oncology, 34(Suppl. 2), S392. Artikel 500O. https://doi.org/10.1016/j.annonc.2023.09.1694

@article{7f9d600157534528956cb2c7e2ac5bc2,

title = "Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study",

author = "Villar, {M. Vieito} and S{\'a}nchez, {J. M. Sep{\'u}lveda} and Garcia, {V. Moreno} and G. Lombardi and A. Stradella and Dahlrot, {R. H.} and Haslund, {C. A.} and M. Geurts and E. Pineda and P. Brandal and {De Vos}, {F. Y .F. L.} and Salgado, {M. A. Vaz} and Garcia, {M. Martinez} and M. Macchini and B. Amoroso and T. Sanchez and B. Hanna and X. Li and Z. Nikolova and M. Simonelli",

note = "Abstrakt No. 500O; ESMO Congress 2023 ; Conference date: 20-10-2023 Through 24-10-2023",

year = "2023",

month = oct,

doi = "10.1016/j.annonc.2023.09.1694",

language = "Dansk",

volume = "34",

pages = "S392",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 2",

url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2023",

}

Villar, MV, Sánchez, JMS, Garcia, VM, Lombardi, G, Stradella, A, Dahlrot, RH, Haslund, CA, Geurts, M, Pineda, E, Brandal, P, De Vos, FYFL, Salgado, MAV, Garcia, MM, Macchini, M, Amoroso, B, Sanchez, T, Hanna, B, Li, X, Nikolova, Z & Simonelli, M 2023, 'Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study', Annals of Oncology, bind 34, nr. Suppl. 2, 500O, s. S392. https://doi.org/10.1016/j.annonc.2023.09.1694

Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study. / Villar, M. Vieito; Sánchez, J. M. Sepúlveda; Garcia, V. Moreno et al.
I: Annals of Oncology, Bind 34, Nr. Suppl. 2, 500O, 10.2023, s. S392.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

AU - Villar, M. Vieito

AU - Sánchez, J. M. Sepúlveda

AU - Garcia, V. Moreno

AU - Lombardi, G.

AU - Stradella, A.

AU - Dahlrot, R. H.

AU - Haslund, C. A.

AU - Geurts, M.

AU - Pineda, E.

AU - Brandal, P.

AU - De Vos, F. Y .F. L.

AU - Salgado, M. A. Vaz

AU - Garcia, M. Martinez

AU - Macchini, M.

AU - Amoroso, B.

AU - Sanchez, T.

AU - Hanna, B.

AU - Li, X.

AU - Nikolova, Z.

AU - Simonelli, M.

N1 - Abstrakt No. 500O

PY - 2023/10

Y1 - 2023/10

U2 - 10.1016/j.annonc.2023.09.1694

DO - 10.1016/j.annonc.2023.09.1694

M3 - Konferenceabstrakt i tidsskrift

SN - 0923-7534

VL - 34

SP - S392

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 2

M1 - 500O

T2 - ESMO Congress 2023

Y2 - 20 October 2023 through 24 October 2023

ER -

Villar MV, Sánchez JMS, Garcia VM, Lombardi G, Stradella A, Dahlrot RH et al. Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study. Annals of Oncology. 2023 okt.;34(Suppl. 2):S392. 500O. doi: 10.1016/j.annonc.2023.09.1694